Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension

BACKGROUND: To evaluate the cost‐effectiveness of combination pulmonary arterial hypertension specific therapy in systemic sclerosis–related PAH. METHODS AND RESULTS: Health outcomes and costs were captured through data linkage. Health utility was derived from Medical Outcomes Study Short Form‐36 sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran‐Duy, An, Morrisroe, Kathleen, Clarke, Philip, Stevens, Wendy, Proudman, Susanna, Sahhar, Joanne, Nikpour, Mandana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174376/
https://www.ncbi.nlm.nih.gov/pubmed/33759539
http://dx.doi.org/10.1161/JAHA.119.015816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174376/
https://www.ncbi.nlm.nih.gov/pubmed/33759539
http://dx.doi.org/10.1161/JAHA.119.015816

Ejemplares similares